Oral desmopressin: A randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis

Journal of Urology

Volumn 158, Issue 3 SUPPL., 1997, Pages 1035-1040

  Skoog, Steven J ^a   Stokes, Arthur ^b   Turner, Katherine L ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

Desmopressin; Enuresis; Urinary incontinence

Indexed keywords

DESMOPRESSIN; NOSE SPRAY;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NOCTURNAL ENURESIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINE INCONTINENCE;

EID: 0030753758     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64383-0     Document Type: Article

References (22)

1. Perlmutter A.D. Enuresis. 2nd ed. P.P. Kelalis L.R. King A.B. Belman Clinical Pediatric Urology vol. 1 1985 W. B. Saunders Co. Philadelphia 311 325 chapt. 13
2. Bakwin H. The genetics of enuresis. I. Kolvin R.C. MacKeith S.R. Meadow Bladder Control and Enuresis 1973 W. Heinemann Medical Books London 73 77 chapt. 9
3. Norgaard J.P. Pedersen E.B. Djurhuus J.C. Diurnal anti-diuretic-hormone levels in enuretics. J. Urol. 134 1985 1029
4. Norgaard J.P. Urodynamics in enuretics. I: reservoir function. Neurourol. Urodyn. 8 1989 199
5. Monda J.M. Husmann D.A. Primary nocturnal enuresis: a comparison among observation, imipramine, desmopressin acetate and bedwetting alarm systems. J. Urol. 154 1995 745
6. Richardson D.W. Robinson A.G. Desmopressin. Ann. Intern. Med. 103 1985 228
7. Williams T.D. Dunger D.B. Lyon C.C. Lewis R.J. Taylor F. Lightman S.L. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-d-arginine vasopressin. I. Studies in adults and children. J. Clin. Endocr. Metab. 63 1986 129
8. Vilhardt H. Lundin S. Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen. Pharmacol. 17 1986 481
9. Vilhardt H. Hammer M. Bie P. Peroral administration of antidiuretic peptides to conscious dogs, normal humans and patients with diabetes insipidus. Front. Horm. Res. 13 1985 314
10. Fjellestad-Paulsen A. Hoglund P. Lundin S. Paulsen O. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin. Endocr. 38 1993 177
11. Rushton H.G. Belman A.B. Zaontz M. Skoog S.J. Sihelnik S. Response to desmopressin as a function of urine osmolality in the treatment of monosymptomatic nocturnal enuresis: a double-blind prospective study. J. Urol. 154 1995 749
12. Moffatt M.E. Harlos S. Kirshen A.J. Burd L. Desmopressin acetate and nocturnal enuresis: how much do we know? Pediatrics 92 1993 420
13. Fjellestad-Paulsen A. Paulsen O. d'Agay-Abensour L. Lundin S. Czemichow P. Central diabetes insipidus: oral treatment with DDAVP. Reg. Peptides 45 1993 303
14. Hammer M. Vilhardt H. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. J. Pharmacol. Exp. Ther. 234 1985 754
15. Stenberg A. Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics 94 1994 841
16. Matthiesen T.B. Rittig S. Djurhuus J.C. Norgaard J.P. Dose titration, and open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J. Urol. 151 1994 460
17. Fjellestad-Paulsen A. Wille S. Harris A.S. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch. Dis. Child. 62 1987 674
18. Matthews D.M. Lis M.T. Cheng B. Crampton R.F. Observations on the intestinal absorption of some oligopeptides of methionine and glycine in the rat. Clin. Sci. 37 1969 751
19. Adibi S.A. Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption. J. Clin. Invest. 50 1971 2266
20. Rushton H.G. Belman A.B. Zaontz M.R. Skoog S.J. Sihelnik S. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J. Urol. 156 1996 651
21. Fergusson D.M. Horwood L.J. Shannon F.T. Factors related to age of attainment of nocturnal bladder control: an 8-year longitudinal study. Pediatrics 78 1986 884
22. Weiss N.A. Hassett M. Conducting a study. J.M. Pepper J.R. Vetere Introductory Statistics. 1987 Addison-Wesley Boston 666 chap. 15